State MN
Clinical Trials in Minnesota
Recruiting clinical trials with at least one study location in Minnesota. Data updated daily from ClinicalTrials.gov.
Top Conditions in Minnesota
NCT07225946 Phase 3
Recruiting
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metas...
Condition
Prostatic Neoplasms, Castration-Resistant
Enrollment
800 pts
Location
United States, Australia, Brazil
Sponsor
Janssen Research & Development
NCT06788886 N/A
Recruiting
Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative D...
Condition
Malignant Brain Neoplasm
Enrollment
147 pts
Location
United States
Sponsor
Mayo Clinic
NCT05797831 Phase 2, Phase 3
Recruiting
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endo...
Condition
Endometrial Cancer
Enrollment
268 pts
Location
United States, Austria, Canada
Sponsor
Kartos Therapeutics, Inc.
NCT06071845 N/A
Recruiting
Assessment of a Minimally Invasive Collection Device for Molecular Analysis of E...
Condition
Barrett Esophagus
Enrollment
400 pts
Location
United States
Sponsor
Mayo Clinic
NCT07129070 N/A
Recruiting
Just-in-Time Training for Youth Mentors
Condition
Mental Health Issue
Enrollment
118 pts
Location
United States
Sponsor
University of Minnesota
NCT06925737 Phase 3
Recruiting
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Pros...
Condition
Prostate Cancer
Enrollment
1,440 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT05910801 Phase 2
Recruiting
Tafasitamab, Lenalidomide and Venetoclax for the Treatment of Relapsed or Refrac...
Condition
Recurrent Mantle Cell Lymphoma
Enrollment
100 pts
Location
United States
Sponsor
Academic and Community Cancer
NCT05327686 Phase 2
Recruiting
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for t...
Condition
Metastatic Renal Cell Carcinoma
Enrollment
240 pts
Location
United States, Australia, Canada
Sponsor
NRG Oncology
NCT04600973 N/A
Recruiting
Improving Implementation of Evidence-based Approaches and Surveillance to Preven...
Condition
Infection
Enrollment
6,000 pts
Location
United States
Sponsor
Trustees of Dartmouth College
NCT05803941 Phase 4
Recruiting
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With ...
Condition
Prostate Cancer
Enrollment
700 pts
Location
United States, Austria, Belgium
Sponsor
Novartis Pharmaceuticals
NCT06568237 Phase 2
Recruiting
A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Mul...
Condition
Multiple System Atrophy
Enrollment
350 pts
Location
United States, France, Germany
Sponsor
Teva Branded Pharmaceutical Pr
NCT06953245 N/A
Recruiting
Collecting Patient-Reported Experiences With Radiation Dermatitis in Breast Canc...
Condition
Breast Carcinoma
Enrollment
20 pts
Location
United States
Sponsor
Mayo Clinic
NCT06723041 N/A
Recruiting
Acupressure for the Reduction of Anxiety in Patients Receiving Cancer-Directed T...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
78 pts
Location
United States
Sponsor
Mayo Clinic
NCT07213466 Phase 4
Recruiting
Individualized Pharmacological Approach to Obesity in Patients With Bipolar Diso...
Condition
Bipolar I Disorder
Enrollment
100 pts
Location
United States
Sponsor
Mayo Clinic
NCT06325202 N/A
Recruiting
Closed Loop and Education for Hypoglycemia Awareness Restoration
Condition
Diabetes Mellitus, Type 1
Enrollment
324 pts
Location
United States, Australia, United Kingdom
Sponsor
Milton S. Hershey Medical Cent
NCT06136650 Phase 3
Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Age...
Condition
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Enrollment
1,314 pts
Location
United States, Australia, Brazil
Sponsor
Merck Sharp & Dohme LLC
NCT05949580 N/A
Recruiting
Study to Evaluate the Usability and Value of Integrated Digital Solutions in Med...
Condition
Relapsing Remitting Multiple Sclerosis
Enrollment
500 pts
Location
United States, Germany
Sponsor
Hoffmann-La Roche
NCT04552275 Phase 1
Recruiting
The HALT Biomarker Study
Condition
Aortic Stenosis
Enrollment
300 pts
Location
United States
Sponsor
Massachusetts General Hospital
NCT05863195 Phase 3
Recruiting
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus St...
Condition
Metastatic Colorectal Carcinoma
Enrollment
408 pts
Location
United States
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT05580562 Phase 3
Recruiting
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study...
Condition
H3 K27M
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Jazz Pharmaceuticals
NCT06395519 Phase 1, Phase 2
Recruiting
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Condition
Advanced or Metastatic Solid Tumors
Enrollment
120 pts
Location
United States
Sponsor
858 Therapeutics, Inc.
NCT05855200 Phase 3
Recruiting
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage ...
Condition
Colonic Neoplasms
Enrollment
892 pts
Location
United States, Argentina, Australia
Sponsor
GlaxoSmithKline
NCT03049254 N/A
Recruiting
Mayo AVC Registry and Biobank
Condition
Arrhythmogenic Right Ventricular Cardiomyopathy
Enrollment
1,000 pts
Location
United States, United Kingdom
Sponsor
Mayo Clinic
NCT07216105 Phase 1
Recruiting
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants...
Condition
Non-Small Cell Lung Cancer
Enrollment
113 pts
Location
United States
Sponsor
Fate Therapeutics
NCT06605430 Phase 2
Recruiting
Medical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer
Condition
Pancreatic Cancer Non-resectable
Enrollment
64 pts
Location
United States
Sponsor
HealthPartners Institute